Waldron Private Wealth LLC Buys New Shares in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Waldron Private Wealth LLC purchased a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,338 shares of the company’s stock, valued at approximately $219,000.

A number of other large investors have also recently added to or reduced their stakes in the company. Pathway Financial Advisers LLC acquired a new position in shares of GE HealthCare Technologies during the 1st quarter worth approximately $25,000. Fred Alger Management LLC bought a new position in GE HealthCare Technologies during the second quarter worth $26,000. BNP Paribas acquired a new position in shares of GE HealthCare Technologies in the first quarter valued at $30,000. Riverview Trust Co bought a new position in shares of GE HealthCare Technologies in the first quarter valued at about $31,000. Finally, Elkhorn Partners Limited Partnership acquired a new stake in shares of GE HealthCare Technologies during the 2nd quarter worth about $31,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

Insider Transactions at GE HealthCare Technologies

In related news, CEO Thomas J. Westrick sold 2,750 shares of the firm’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total value of $222,145.00. Following the sale, the chief executive officer now directly owns 17,509 shares of the company’s stock, valued at $1,414,377.02. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.27% of the stock is owned by insiders.

GE HealthCare Technologies Trading Down 0.0 %

GEHC opened at $89.29 on Thursday. The company has a quick ratio of 0.82, a current ratio of 1.06 and a debt-to-equity ratio of 1.05. GE HealthCare Technologies Inc. has a twelve month low of $62.35 and a twelve month high of $94.55. The stock has a market capitalization of $40.76 billion, a price-to-earnings ratio of 26.11, a P/E/G ratio of 3.39 and a beta of 1.18. The company has a 50-day simple moving average of $88.16 and a 200 day simple moving average of $83.37.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.98 by $0.02. The business had revenue of $4.84 billion for the quarter, compared to analyst estimates of $4.88 billion. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The firm’s revenue for the quarter was up .5% on a year-over-year basis. During the same quarter last year, the business posted $0.92 EPS. Analysts predict that GE HealthCare Technologies Inc. will post 4.26 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a $0.03 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.13%. GE HealthCare Technologies’s payout ratio is 3.51%.

Wall Street Analyst Weigh In

A number of brokerages recently commented on GEHC. Evercore ISI upped their price target on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a research note on Tuesday, October 1st. Redburn Atlantic upgraded GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. UBS Group downgraded GE HealthCare Technologies from a “neutral” rating to a “sell” rating and reduced their price target for the company from $84.00 to $74.00 in a research note on Thursday, September 26th. JPMorgan Chase & Co. started coverage on GE HealthCare Technologies in a research report on Monday, September 9th. They set a “neutral” rating and a $90.00 price objective on the stock. Finally, Stifel Nicolaus lifted their target price on GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a report on Monday, September 30th. One analyst has rated the stock with a sell rating, five have assigned a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $94.23.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.